参考文献/References:
[1].January CT,Wann LS,Alpert JS,et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation:executive summary:a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society[J]. Circulation,2014,130(23):2071-2104.
[2].[2] Ha?ssaguerre M,Ja?sP,Shah DC,et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins[J]. N Engl J Med,1998,339(10):659-666.
[3].[3] Verma A,Jiang CY,Betts TR,et al. Approaches to catheter ablation for persistent atrial fibrillation[J]. N Engl J Med,2015,372(19):1812-1822.
[4].[4] Verma A,Wazni OM,Marrouche NF,et al. Pre-existent left atrial scarring in patients undergoing pulmonary vein antrum isolation:an independent predictor of procedural failure[J]. J Am Coll Cardiol,2005,45(2):285-292.
[5].[5] Schreiber D,Rieger A,Moser F,et al. Catheter ablation of atrial fibrillation with box isolation of fibrotic areas:lessons on fibrosis distribution and extent,clinical characteristics,and their impact on long-term
[6].outcome[J]. J Cardiovasc Electrophysiol,2017,28(9):971-983.
[7].[6] Kosiuk J,Dinov B,Kornej J,et al. Prospective,multicenter validation of a clinical risk score for left atrial arrhythmogenic substrate based on voltage analysis:DR-FLASH score[J]. Heart Rhythm,2015,12(11):2207-2212.
[8].[7] Kottkamp H. Fibrotic atrial cardiomyopathy:a specific disease/syndrome supplying substrates for atrial fibrillation,atrial tachycardia,sinus node disease,AV node disease,and thromboembolic complications[J]. JCardiovasc Electrophysiol,2012,23(7):797-799.
[9].[8] Daccarett M,Badger TJ,Akoum N,et al. Association of left atrial fibrosis detected by delayed-enhancement magnetic resonance imaging and the risk of stroke in patients with atrial fibrillation[J].J Am CollCardiol,2011,57(7):831-838.
[10].[9] Mahnkopf C,Badger TJ,Burgon NS,et al. Evaluation of the left atrial substrate in patients with lone atrial fibrillation using delayed-enhanced MRI:implications for disease progression and response to catheter ablation[J]. Heart Rhythm,2010,7(10):1475-1481.
[11].[10] Marrouche NF,Wilber D,Hindricks G,et al. Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation:the DECAAF study[published correction appears in JAMA[J]. JAMA,2014,311(5):498-506.
[12].[11] Rolf S,Kircher S,Arya A,et al. Tailored atrial substrate modification based on low-voltage areas in catheter ablation of atrial fibrillation[J]. Circ Arrhythm Electrophysiol,2014,7(5):825-833.
[13].[12] Kottkamp H,Berg J,Bender R,et al. Box isolation of fibrotic areas(BIFA):a patient-tailored substrate modification approach for ablation of atrial fibrillation[J]. J Cardiovasc Electrophysiol,2016,27(1):22-30.
[14].[13] Kottkamp H,Schreiber D,Moser F,et al. Therapeutic approaches to atrial fibrillation ablation targeting atrial fibrosis[J]. JACC Clin Electrophysiol,2017,3(7):643-653.
[15].[14] Kapa S,Desjardins B,Callans DJ,et al. Contact electroanatomic mapping derived voltage criteria for characterizing left atrial scar in patients undergoing ablation for atrial fibrillation[J]. J Cardiovasc Electrophysiol,2014,25(10):1044-1052.
[16].[15] Tschabrunn CM,Roujol S,Dorman NC,et al. High-resolution mapping of ventricular scar:comparison between single and multielectrode catheters[J]. Circ Arrhythm Electrophysiol,2016,9(6):10.
[17].[16] Yagishita A,Oliveira S,Cakulev I,et al. Correlation of left atrial voltage distribution between sinus rhythm and atrial fibrillation:identifying structural remodeling by 3-D electroanatomic mapping irrespectiveof the rhythm[J]. J Cardiovasc Electrophysiol,2016,27(8):905 -912.
[18].[17] Goette A,Kalman JM,Aguinaga L,et al. EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies:definition,characterization,and clinical implication[J]. Europace,2016,18(10):1455-1490.
[19].[18] Moser F,Rieger A,P?nisch C,et al. A novel ablation approach in atrial fibrillation patients undergoing fibrotic-based substrate modification:targeting the bachmann’s bundle?[J]. J Cardiovasc Electrophysiol,2018,29(6):844-853.
[20].[19] Yang G,Yang B,Wei Y,et al. Catheter ablation of nonparoxysmal atrial fibrillation using electrophysiologically guided substrate modification during sinus rhythm after pulmonary vein isolation[J]. Circ Arrhythm Electrophysiol,2016,9(2):e003382.
[21].[20] Yamaguchi T,Tsuchiya T,Nakahara S,et al. Efficacy of left atrial voltage‐based catheter ablation of persistent atrial fibrillation[J]. J Cardiovasc Electrophysiol,2016 ,27(9):1055-1063.
[22].[21] Platonov PG,Mitrofanova LB,Orshanskaya V,et al. Structural abnormalities in atrial walls are associated with presence and persistency of atrial fibrillation but not with age[J]. J Am Coll Cardiol,2011,58(21):2225-2232.
[23].[22] Mohanty S,Mohanty P,di Biase L,et al. Long-term follow-up of patients with paroxysmal atrial fibrillation and severe left atrial scarring:comparison between pulmonary vein antrum isolation only or pulmonary vein isolation combined with either scar homogenization or trigger ablation[J]. Europace,2017,19(11):1790-1797.
[24].[23] Seitz J,Bars C,Théodore G,et al. AF ablation guided by spatiotemporal electrogram dispersion without pulmonary vein isolation:a wholly patient-tailored approach[J]. J Am Coll Cardiol,2017,69(3):303-321.
相似文献/References:
[1]贺鹏康,周菁.心房颤动治疗新技术——冷冻球囊消融[J].心血管病学进展,2016,(1):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
HE Pengkang,ZHOU Jing.Cryoballoon Ablation, A Novel Technology for Atrial Fibrillation Treatment[J].Advances in Cardiovascular Diseases,2016,(11):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
[2]都明辉,施海峰*,佟佳宾,等.心房颤动消融相关性无症状性脑缺血[J].心血管病学进展,2016,(1):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
DU Minghui,SHI Haifeng*,TONG Jiabin,et al.Silent Cerebral Ischemia Related to Atrial Fibrillation Ablation[J].Advances in Cardiovascular Diseases,2016,(11):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
[3]郑环杰,综述,肖骅,等.心房颤动抗栓治疗研究进展[J].心血管病学进展,2016,(2):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
ZHENG Huanjie,XIAO Hua.Progress of Antithrombotic Therapy in Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(11):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
[4]张清,综述,罗素新,等.新型Xa 因子抑制剂———依度沙班在心房颤动患者抗凝治疗中的研究进展[J].心血管病学进展,2016,(2):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
ZHANG Qing,LUO Suxin,TANG Jiong.Novel Factor Xa Inhibitors—Edoxaban in Prevention of Stroke in
Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(11):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
[5]胡红玲,综述,罗素新,等.预防非瓣膜性心房颤动性脑卒中的治疗新进展[J].心血管病学进展,2016,(3):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
HU Hongling,LUO Suxin.New Progress in the Treatment for Cerebral Apoplexy of Nonvalvular
Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(11):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
[6]王超,杨国澍,综述,等.关附甲素治疗心房颤动的研究进展[J].心血管病学进展,2016,(3):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
WANG Chao,YANG Guoshu,CAI Lin,et al.Research Progress of the Treatment of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(11):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
[7]徐小东,综述,杨东辉,等.决奈达隆治疗心房颤动的现状及展望[J].心血管病学进展,2016,(4):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
XU Xiaodong,YANG Donghui.Status and Prospect of Dronedarone in Treating Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(11):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
[8]张莎,储国俊,吴弘.经导管左心耳封堵术的临床应用进展[J].心血管病学进展,2015,(5):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
ZHANG Sha,CHU Guojun,WU Hong.Clinial Application Advances in Left Atrial Appendage Closure[J].Advances in Cardiovascular Diseases,2015,(11):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
[9]汪俊,杨浩.心房颤动射频消融的术式演变[J].心血管病学进展,2015,(5):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]
WANG Jun,YANG Hao.Evolution of Radiofrequency Ablation of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2015,(11):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]
[10]赵璐,苏立.心房颤动与离子通道重构研究进展[J].心血管病学进展,2015,(5):580.[doi:10.3969/j.issn.1004-3934.2015.05.014]
ZHAO Lu,SU Li.Research Progress of Atrial Fibrillation and Ion Channel Remodeling[J].Advances in Cardiovascular Diseases,2015,(11):580.[doi:10.3969/j.issn.1004-3934.2015.05.014]